Documents

4th Core Group Meeting. COST Action 17112 PRO-EURO DILI NET. 26th November 2020. 2.00-3.00 PM (GMT)

CA-17112 Management Committee updates & Working Groups meeting @ EASL Digital International Liver Congress 2020

Core Group Meetings (CGM)

Management Committee Meetings (MCM)

Working Group Meetings (WGM)

2nd TRAINING COURSE, COST ACTION 17-112: RECENT ADVANCES ON STEM CELL RESEARCH AND CELL THERAPIES.

Lisbon, Portugal. 10th-11th Octuber 2019

1st TRAINING COURSE, COST ACTION 17-112: ASSESSMENT OF DRUG-INDUCED LIVER INJURY: KEY RULES AND COMMON PITFALLS. HOW TO MAKE A CLINICAL NARRATIVE.

Recognition by EUROTOX as a Continuing professional development (CPD) course of 11 teaching hours.

Short-Term Scientific Missions (STSMs). COST ACTION 17-112

• ECOST-STSM-Request-CA17112-45122. “SHORT TERM SCIENTIFIC MISSION” FOR THE LIVER FIBROSIS DIAGNOSIS THROUGH THE LIVER ELASTROGRAPHY. 

*Participant: Enrique del Campo, UMA. Málaga (Spain)

*Type of Mission: Clinical

*Location: Internal Medicine & Hepatology, DIBIMIS, University of Palermo (Italy)

*Responsible: Dr. Anna Licata

*Dates: 10.07.2019-18.10.2019

• ECOST-STSM-Request-CA17112-45133. VIRAL AND AUTOIMMUNE HEPATITIS, CIRRHOSIS, ACUTE LIVER FAILURE, DILI, HILI INTRAHEPATIC CHOLESTASIS OF PREGNANCY
  

*Participant: Goran Bokan Faculty of medicine, Banja Luka, BA

*Type of Mission: Clinical

*Location: Internal Medicine & Hepatology, DIBIMIS, University of Palermo (Italy)

*Responsible: Dr. Anna Licata

*Dates: 30.09.2019-31.10.2019

• ECOST-STSM-Request-CA17112-45167. ROLE OF NRF2 IN APAP-MEDIATED TOXICITY

*Participant: Nuria López-Alcántara (Spain)

*Type of Mission: Basic

*Location: Institute of Physics of the Czech Academy of Sciences, Prague (Czech Republic)

*Responsible: Dr. Oleg Lunov

*Dates: 02.12.2019-22.12.2019

• ECOST-STSM-Request-CA17112-47460. DILI principles in detection, characterization, phenotyping, risk assessment and adjudication. Management of DILI databases. Pathophysiology, therapeutic strategies and new biomarkers in DILI using patient-derived dermal fibroblasts, keratinocytes and hep

*Participant: Lauryna Aukštikalnė. Lithuanian University of Health Sciences Institute of Physiology and Pharmacology (Kaunas)

*Type of Mission: Clinical

*Location: Universidad de Málaga (UMA), Málaga, Spain

*Responsible: Dr. María Isabel Lucena, lucena@uma.es

*Dates: 2021-01-11 – 2021-02-28

• ECOST-STSM-Request-CA17112-46089. Methodology of systematic review of observational studies in DILI

*Participant: Cristiana Torres Freixo, Faculdade de Medicina. Universidade do Porto. Porto (Portugal)

*Type of Mission: Clinical

*Location: Nottingham Digestive Diseases Centre, Nottingham (UK)

*Responsible: Dr. Guruprasad Aithal

*Dates: 19.01.2020-05.02.2020

• ECOST-STSM-Request-CA17112-46009. Training in the use of HepaRGs and monitoring POR expression.

*Participant: Francisco Esteves. Faculdade de Ciências Médicas, UNL, Lisboa (Portugal).

*Type of Mission: Basic

*Location: Institute of Bioengineering, University of Edinburgh, Scotland (UK)

*Responsible: Dr. Leonard J. Nelson

*Dates: 01.03.2020-15.03.2020

2ND PROGRESS REPORT (PR2) OF THE COST ACTION 17112

CA17112_PR2_ActionChairReport_2020-12-03

FIRST PROGRESS REPORT (PR1) OF THE COST ACTION 17112

DECALOGUE OF ACTIONS TO ALIGN WITH COST STRATEGIC POLICY

NEWSLETTERS

The Management Committee has approved the ITC conference grant awarded to the PhD Student, Ms. Joana Saraiva (Portugal) with the purpose of her attendance for the EUROTOX congress 2019  hold in Helsinki (8-11 September).

Her abstract entitled: “Hepatocyte-like cells in microfluidic devices: a new platform for disease modelling, drug screening and toxicology”
(Abstract ID: 250), submitted as “Poster” has been accepted and selected one of the 5 top posters presentation. She has adquired new concepts in pre-clinical methods in DILI that undoubtedly will help her to successfully continue her research on the field of DILI.